Short description
BrightGene is a biopharma company.
Description
BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, BrightGene invests in all stage therapeutics and innovations.
Last funding
No Way
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Suzhou, Jiangsu, China, Asia
Founded on
January 1, 2001
Exited on
November 8, 2019
Went public on
November 8, 2019
Stock symbol
688166
Non-profit?
No
Acquired?
No
Employees count
501-1000
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noway Youcantaccess, Noaccess, Noway Youcantaccess, No Way
Sign in for full access
Founders
Jiandong Yuan
Funding rounds count
4
Portfolio organisations count
No Way, Noaccess
Sign in for full access